Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
German cockroach allergenic extract is a non-standardized biologic preparation derived from the German cockroach (Blattella germanica). It contains a mixture of proteins and allergens from the whole insect or its secretions and remains. The primary use is for allergy diagnosis via skin testing and for allergen-specific immunotherapy (hyposensitization) in patients with confirmed IgE-mediated sensitivity to German cockroach allergens. The mechanism of action involves exposure to specific allergens that trigger an immune response; diagnostic use relies on histamine release upon IgE cross-linking on mast cells, while therapeutic administration aims to induce immune tolerance by increasing IgG production and regulatory T cell activity, thereby reducing allergic symptoms over time. Extracts are typically administered percutaneously or intradermally for diagnosis, and subcutaneously for immunotherapy[2][3][8]. These extracts are not standardized in terms of potency or content but may be labeled by weight/volume. They are preserved in glycerin-containing solutions to maintain stability[5][6]. Indications include diagnostic testing and treatment of allergic disease when avoidance is not possible.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on german cockroach allergenic extract.